Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2012

Dec 4, 2012

30718_dirs_2012-12-04_c36d4081-a8fb-4952-84e7-775de738f858.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2012-11-30

Reporting Person: MELSEN GREGORY J (CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-11-30 Stock Option $70.9 A 15000 Acquired 2019-11-29 Common Stock (15000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 426 Direct
Common Stock 725 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $74.05 2019-07-26 Common Stock (1755) 1755 Direct
Stock Option $76.15 2018-07-27 Common Stock (1803) 1803 Direct
Stock Option $58.4 2017-07-29 Common Stock (2083) 2083 Direct
Stock Option $66.25 2017-04-29 Common Stock (30000) 30000 Direct
Stock Option $62.46 2016-07-23 Common Stock (203) 203 Direct
Stock Option $79.41 2015-07-24 Common Stock (596) 596 Direct
Stock Option $56.83 2014-07-26 Common Stock (783) 783 Direct
Stock Option $49.43 2013-07-26 Common Stock (1012) 1012 Direct
Stock Option $39.53 2014-12-16 Common Stock (25000) 25000 Direct

Footnotes

F1: Vest 7,500 each 4/30/11, 4/30/12, 4/30/13, 4/30/14